Donate

Morgan Adams Foundation

Just 4% of the National Cancer Institute's research budget is allocated to pediatric cancer, so the burden falls almost entirely to the private sector. Kids' cancers are vastly different from adult cancers and must be treated as such. Please help us fund kids' cancer research that saves lives!

More Information

Fundraising Pages

Want to do more for your favorite charity? We’ve made it easy for you to raise money by creating a personalized fundraising page.

Start a fundraiser Current fundraisers for this charity (0)

Education and Outreach

Class

Medical Research 

Beneficiaries

Children ages 5 to 21
Children and Youth (infants - 19 years)
Infants/Babies (under age 5)
Young Adults (20-25 years)
Adolescents/Youth (13-19 years)

Description

The Morgan Adams Foundation is an ongoing resource for information on childhood, adolescent and young adult cancers, their current treatments and the need for ongoing new treatment development. Through our ongoing efforts, MAF builds community awareness of the need to support Childhood cancer research, as well as of the need to ensure that the children affected by this disease have the best possible treatment options made available to them.

The Morgan Adams Foundation hosts educational events for the public throughout the year, including:

- Children's Hospital of Colorado campus and lab tours (6-10 per year)
- Annual educational breakfasts - attendees learn about the latest in pediatric cancer therapies and research from the doctors and patients directly supported by the Foundation
- A vibrant and robust cancer awareness program (monthly)

Photos

Evidence of Program's Success

The Morgan Adams Foundation's educational and awareness programs have increased donor and volunteer involvement in our programs and have improved our reach in the community. These efforts have directly supported our fundraising activities and success.

Funding Research

Class

Medical Research 

Beneficiaries

Children ages 5 to 21
Children and Youth (infants - 19 years.)
Infants/Babies (under age 5)
Young Adults (20-25 years)
Adolescents/Youth (13-19 years)

Description

Our goal, as we grow, is to fund an ever-increasing number of new research projects and studies that will produce better therapies for children with cancer. We will:

-Continue to provide funding for both basic science and clinical investigations in the areas of pediatric oncology and neuro-oncology which will translate into potential therapies for pediatric cancer;

-Increase overall funding of collaborative trials organizations studies designed to speed the development of new therapies for children with cancer; and

-Assist children, their families and caregivers in coping with the diagnosis and treatment of cancer by providing access to community resources and quality of life programs.

Photos

Evidence of Program's Success

Funding from the Morgan Adams Foundation has increased researchers' access to tumor genetic profiling through a variety of deep sequencing technologies, including MicroArray Gene Chips. These technologies give them an increased understanding of the composition of the cancers involved, so that they can better determine at diagnosis if a patient is at high or low risk.

Here's some of the success stories achieved through our MicroArray GeneChip program:

Kuhu is a thriving college student thanks to the chemotherapy treatment she received as a result of the MicroArray Chip program funded by The Morgan Adams Foundation. By analyzing data collected through Chipped tissue samples, researchers identified a mutation that allowed them to change how they treated Kuhu's tumor - which saved her life!

Caden actually benefited from Kuhu's ordeal. What they learned from the Chip data used to treat Kuhu helped them refine Caden's treatments when he was only 2 years old. Today he's a happy second grader. Chips rule!

Grace also benefited from the Chip program. By analyzing Chip data, Grace's tumor was found to have characteristics of two different types of brain tumors. This information enabled doctors to modify her therapy and treat for both tumor elements, offering the realistic chance of a cure that would not have been possible had the diagnosis been based simply on traditional methods.

Key aspects of this profile information have been reviewed by Community First Foundation staff. Each organization is exclusively responsible for the content that appears on the profile page. Community First Foundation offers general guidance as to the purpose of each area but does not require or encourage charities to include anything in particular in each section.